| Nov 21 |
The FDA Can’t Decide Whether Zepbound Is in Shortage. It’s Good News for Hims & Hers Stock.
|
| Nov 21 |
Eli Lilly Stock Tumbles As Kennedy Targets Weight Loss Drugs
|
| Nov 21 |
Pfizer Secures Approval for Hemophilia Drug Hympavzi in the EU
|
| Nov 21 |
Eli Lilly and 2 More Drug Stocks to Buy After RFK-Inspired Drop
|
| Nov 20 |
More companies covering weight loss drugs for their employees
|
| Nov 20 |
Weight loss drug makers want more insurance plans to cover Wegovy and Zepbound
|
| Nov 20 |
Is Novo Nordisk Stock a Buy Right Now?
|
| Nov 20 |
RFK Jr. Sparks New Worries About Obesity Drugs. Here’s What Investors Should Focus on Instead.
|
| Nov 19 |
Novo Nordisk semaglutide phase 3 trial for MASH meets primary endpoints
|
| Nov 19 |
Sector Update: Health Care Stocks Decline
|
